Vergelijking
Dulaglutide vs. Maridebart Cafraglutide
Twee peptiden naast elkaar — identiteit, bewijsbasis, juridische status en bekende bijwerkingen.
Identiteit
Categorie
Metabool
Metabool
CAS-nr.
923950-08-7
geen gegevens
Molecuulmassa
59670 g/mol
geen gegevens
Halfwaardetijd
110 h
geen gegevens
Sequentie
GLP-1(7-37)-Variante kovalent verbunden mit modifiziertem humanen IgG4-Fcgeen gegevens
Werkingsmechanisme
Dulaglutide
Dulaglutide consists of two modified GLP-1(7-37) sequences covalently linked to a human IgG4-Fc. The Fc fusion increases molecular weight substantially (~60 kDa), reduces renal filtration and extends the half-life to several days. GLP-1 receptor activation glucose-dependently stimulates insulin secretion, inhibits glucagon, delays gastric emptying and modulates central satiety signalling.
Maridebart Cafraglutide
MariTide combines GLP-1 receptor agonism with GIP receptor antagonism in an antibody-peptide conjugate. Its long duration of action allows infrequent (monthly) dosing.
Bewijsbasis
Hoogste bewijs
Humane RCT
Humane RCT
Studies
5
1
waarvan bij mensen
5
1
Geregistreerde effecten
3
2
Openstaande tegenstrijdigheden
1
0
Gedocumenteerde bijwerkingen
2
1
Juridische status
Volledige vermeldingen
Frequently asked questions
- What is the difference between Dulaglutide and Maridebart Cafraglutide?
- Dulaglutide is classified as "Metabool", while Maridebart Cafraglutide is classified as "Metabool". Dulaglutide: GLP-1 receptor agonist designed as a fusion protein of two modified GLP-1(7-37) sequences covalently linked to a human IgG4-Fc fragment. FDA-approved 2014 (Trulicity) for type 2 diabetes; EMA approval 2014. Maridebart Cafraglutide: Maridebart cafraglutide (MariTide, Amgen) is a bispecific molecule: a GLP-1 receptor agonist combined with a GIP receptor antagonist, designed for monthly dosing; in phase 3 for obesity. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
- Which peptide is better supported by science, Dulaglutide or Maridebart Cafraglutide?
- The highest available evidence level is "Humane RCT" for Dulaglutide and "Humane RCT" for Maridebart Cafraglutide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
- What is the legal status of Dulaglutide and Maridebart Cafraglutide in Germany and the United States?
- Duitsland: Dulaglutide — Op recept, Maridebart Cafraglutide — Niet goedgekeurd. Verenigde Staten: Dulaglutide — Op recept, Maridebart Cafraglutide — Niet goedgekeurd. These are factual summaries with source and review date on the individual pages.